Biohaven (BHVN) Other financing activities (2021 - 2025)
Biohaven (BHVN) reported Other financing activities of -$1.8 million for Q4 2025, up 72.14% on a YoY basis from -$1.0 million in Q4 2024, and down 212.37% sequentially from $1.6 million in Q3 2025.
Biohaven (BHVN) Other financing activities (2021 - 2025) Analysis & Trends
Biohaven (BHVN) has 5 years of Other financing activities data on file, last reported at -$1.8 million in Q4 2025.
- For the quarter ending Q4 2025, Other financing activities rose 72.14% year-over-year to -$1.8 million; the trailing twelve-month figure through Mar 2026 stood at -$563000.0 (down 140.01% YoY), and the FY2025 full-year result was -$194000.0, down 108.59% from the prior year.
- Other financing activities declined to -$1.8 million in Q4 2025, from $1.6 million in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $86.8 million in Q2 2022 to a low of -$252.4 million in Q4 2021.
- A 5-year average of -$21.0 million and a median of $794000.0 in 2023 frame the typical range for Other financing activities.
- Peak annual rise in Other financing activities reached 456.48% in 2024, while the deepest fall reached 234.7% in 2024.
- Tracing BHVN's Other financing activities over 5 years: stood at -$252.4 million in 2021, then gained by 6.11% to -$237.0 million in 2022, then jumped by 101.98% to $4.7 million in 2023, then plunged by 234.7% to -$6.3 million in 2024, then surged by 72.14% to -$1.8 million in 2025.
- Business Quant data shows BHVN's Other financing activities at -$1.8 million in Q4 2025, $1.6 million in Q3 2025, and -$369000.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Biohaven | 2.13 Bn | 1.78 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.76 Mn |
| Dec 31, 2025 | -1.76 Mn |
| Sep 30, 2025 | 1.57 Mn |
| Sep 30, 2025 | 1.57 Mn |
| Jun 30, 2025 | -369,000.00 |
| Jun 30, 2025 | -369,000.00 |
| Mar 31, 2025 | 369,000.00 |
| Mar 31, 2025 | 369,000.00 |
| Dec 31, 2024 | -6.32 Mn |
| Dec 31, 2024 | -6.32 Mn |
| Sep 30, 2024 | 4.01 Mn |
| Sep 30, 2024 | 4.01 Mn |
| Jun 30, 2024 | 3.35 Mn |
| Jun 30, 2024 | 3.35 Mn |
| Mar 31, 2024 | 1.22 Mn |
| Mar 31, 2024 | 1.22 Mn |
| Dec 31, 2023 | 4.70 Mn |
| Dec 31, 2023 | 4.70 Mn |
| Sep 30, 2023 | -1.13 Mn |
| Sep 30, 2023 | -1.13 Mn |